Harvard diabetes researcher retracts third paper
A prominent diabetes researcher based at Harvard Medical School has retracted a third paper, citing manipulation of multiple figures. Late last year, Carl Ronald Kahn—also chief academic officer at Joslin Diabetes Center—retracted two papers for similar reasons. In November, Kahn pulled a 2005 paper from The Journal of Clinical Investigation (JCI) and a month later, he retracted a 2003 paper from The … Continue reading Harvard diabetes researcher retracts third paper